Immunohistochemistry staining of TNBC samples revealed that RNF40 and H2Bub1 expression is maintained at various levels in all primary and in the vast majority of brain metastatic lesions, aligning with our recent report on HER2+-BC [27] (Fig. 2B). This evidence concerns the gene RNF40 and breast cancer.